medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2022, Number 4

<< Back Next >>

Acta Pediatr Mex 2022; 43 (4)

The relationship between maternal serum apelin-36 level and anthropometric indices up to 18 months after birth; A Cohort Study

Pouraliroudbaneh S, Tehranian N, Saber A, Sadat-Esmaeilzadeh M, Kazemnejad A

Language: English
References: 35
Page: 221-229
PDF size: 293.39 Kb.


ABSTRACT

Background & Objective: Apelin plays an important role in regulating energy intake and homeostasis. This study aims to investigate the relationship between maternal serum apelin-36 and infants’ anthropometric markers up to 18 months after birth.
Materials & Methods: In this cohort study, 166 pregnant women aged 18-40 years old third trimester period referred to the Prenatal Clinic, participated in this study. The women were divided into two groups: an elective cesarean section group (as an exposure; n = 23), and a vaginal delivery group (as a non-exposure; n = 22). Maternal serum Apelin-36 levels were measured during the third trimester period and after delivery using ELISA. Infants were followed for up to 18 months during the postpartum period.
Results: The serum level of Apelin-36 after delivery was significantly and positively correlated with the weight of infants at 12 months, and 18 months P‹0.05. It was also correlated with the height of infants at 6 months P‹0.05 and 18 months P‹0.05. Additionally, Apelin-36 was significantly correlated with the head circumference at 12 months P ‹ 0.05.
Conclusiones: The maternal serum Apelin-36 level showed a relationship with the infant’s anthropometric indicators and gender.


REFERENCES

  1. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W,Kumano K, et al. The novel peptide apelin lowers bloodpressure via a nitric oxide-dependent mechanism. Regulatorypeptides. 2001;99(2-3):87-92.

  2. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y,Hinuma S, et al. Molecular and functional characteristiCSof APJ. Tissue distribution of mRNA and interaction withthe endogenous ligand apelin. The Journal of biologicalchemistry. 2000;275(28):21061-7.

  3. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R,Hinuma S, et al. Molecular properties of apelin: tissuedistribution and receptor binding. 2001;1538(2-3):162-71.

  4. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T,Zou MX, et al. Isolation and characterization of a novelendogenous peptide ligand for the human APJ receptor.Biochemical and biophysical research communications.1998;251(2):471-6.

  5. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y,et al. Characterization of Apelin, the Ligand for the APJReceptor. 2000;74(1):34-41.

  6. Esteve E, Ricart W, Fernández-Real JM. Adipocytokines andinsulin resistance: the possible role of lipocalin-2, retinolbinding protein-4, and adiponectin. Diabetes Care. 2009;32Suppl 2(Suppl 2):S362-S7.

  7. Trayhurn P, Wood IS. Adipokines: inflammation and thepleiotropic role of white adipose tissue. The British journalof nutrition. 2004;92(3):347-55.

  8. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, MatsudaT, et al. Apelin is a novel angiogenic factor in retinalendothelial cells. Biochemical and biophysical researchcommunications. 2004;325(2):395-400.

  9. Bonora E, Brangani C, Pichiri I. [Abdominal obesity anddiabetes]. Giornale italiano di cardiologia (2006). 2008;9(4Suppl 1):40s-53s.

  10. Boucher Jrm, Masri B, Daviaud Dl, Gesta Sp, Guigné C,Mazzucotelli A, et al. Apelin, a Newly Identified AdipokineUp-Regulated by Insulin and Obesity. Endocrinology.2005;146(4):1764-71.

  11. Kleinz MJ, Davenport AP. Immunocytochemical localizationof the endogenous vasoactive peptide apelin to humanvascular and endocardial endothelial cells. Regulatorypeptides. 2004;118(3):119-25.

  12. Kralisch S, Lossner U, Bluher M, Paschke R, Stumvoll M,Fasshauer M. Growth hormone induces apelin mRNAexpression and secretion in mouse 3T3-L1 adipocytes.Regulatory peptides. 2007;139(1-3):84-9.

  13. Jia YX, Pan CS, Zhang J, Geng B, Zhao J, Gerns H, et al. Apelinprotects myocardial injury induced by isoproterenol in rats.Regulatory peptides. 2006;133(1-3):147-54.

  14. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P,Jimenez-Chillaron JC, et al. Sexual differentiation, pregnancy,calorie restriction, and aging affect the adipocyte-specificsecretory protein adiponectin. Diabetes. 2003;52(2):268-76.

  15. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, QuilliotD, et al. TNFalpha up-regulates apelin expression in humanand mouse adipose tissue. FASEB journal : officialpublication of the Federation of American Societies forExperimental Biology. 2006;20(9):1528-30.

  16. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, DhilloW, et al. The effects of centrally administered apelin-13 onfood intake, water intake and pituitary hormone releasein rats. Biochemical and biophysical research communications.2002;291(5):1208-12.

  17. Eberlé D, Marousez L, Hanssens S, Knauf C, Breton C,Deruelle P, et al. Elabela and Apelin actions in healthyand pathological pregnancies. Cytokine & growth factorreviews. 2019;46:45-53.

  18. Cetin I, Antonazzo P. The role of the placenta in intrauterinegrowth restriction (IUGR). Zeitschrift fur Geburtshilfe undNeonatologie. 2009;213(3):84-8.

  19. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA.Apelin, the ligand for the endothelial G-protein-coupledreceptor, APJ, is a potent angiogenic factor required fornormal vascular development of the frog embryo. Developmentalbiology. 2006;296(1):177-89.

  20. Çatlı G, Olgaç Dündar N, Dündar BN. Adipokines inbreast milk: an update. J Clin Res Pediatr Endocrinol.2014;6(4):192-201.

  21. Kurowska P, Barbe A, Różycka M, Chmielińska J, Dupont J,Rak A. Apelin in Reproductive Physiology and Pathology ofDifferent Species: A Critical Review. International Journalof Endocrinology. 2018;2018:9170480.

  22. Tehranian N PRS, Esmaeil Zadeh MS, Saber MashhadToroghi A, Kazem Nezhad A, Hajimirzaei SS, Mousavi M.Apelin and Difference in Cesarean Section and NormalVaginal Delivery. J womens health Issues Care 2018;7(2).

  23. Cekmez F, Canpolat FE, Pirgon O, Çetinkaya M, Aydinoz S, SuleymanogluS, et al. Apelin, vaspin, visfatin and adiponectinin large for gestational age infants with insulin resistance.Cytokine. 2011;56(2):387-91.

  24. Aslan M, Celik O, Celik N, Turkcuoglu I, Yilmaz E, Karaer A, etal. Cord blood nesfatin-1 and apelin-36 levels in gestationaldiabetes mellitus. Endocrine. 2012;41(3):424-9.

  25. Malamitsi-Puchner A, Gourgiotis D, Boutsikou M, Baka S,Hassiakos D, Briana DD. Circulating apelin concentrations inmother/infant pairs at term. Acta paediatrica (Oslo, Norway: 1992). 2007;96(12):1751-4.

  26. Aydin S. The presence of the peptides apelin, ghrelin andnesfatin-1 in the human breast milk, and the lowering oftheir levels in patients with gestational diabetes mellitus.Peptides. 2010;31(12):2236-40.

  27. Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y,Hinuma S, et al. Apelin, the natural ligand of the orphanreceptor APJ, is abundantly secreted in the colostrum. Biochimicaet Biophysica Acta (BBA) - Molecular Cell Research.1999;1452(1):25-35.

  28. Bertrand C, Valet P, Castan-Laurell I. Apelin and energymetabolism. 2015;6(115).

  29. Wang G, Anini Y, Wei W, Qi X, O’Carroll A-M, Mochizuki T, etal. Apelin, a new enteric peptide: localization in the gastrointestinaltract, ontogeny, and stimulation of gastric cell proliferationand of cholecystokinin secretion. 2004;145(3):1342-8.

  30. Higuchi K, Masaki T, Gotoh K, Chiba S, Katsuragi I, Tanaka K,et al. Apelin, an APJ receptor ligand, regulates body adiposityand favors the messenger ribonucleic acid expression ofuncoupling proteins in mice. 2007;148(6):2690-7.

  31. Than A, Cheng Y, Foh L-C, Leow MK-S, Lim SC, Chuah YJ, etal. Apelin inhibits adipogenesis and lipolysis through distinctmolecular pathways. Molecular and Cellular Endocrinology.2012;362(1):227-41.

  32. Pei Z, Heinrich J, Fuertes E, Flexeder C, Hoffmann B, LehmannI, et al. Cesarean delivery and risk of childhood obesity.2014;164(5):1068-73. e2.

  33. Liang J, Zhang Z, Yang W, Dai M, Lin L, Chen Y, et al. Associationbetween cesarean section and weight statusin Chinese children and adolescents: a national survey.2017;14(12):1609.

  34. Yuan C, Gaskins AJ, Blaine AI, Zhang C, Gillman MW, MissmerSA, et al. Association Between Cesarean Birth and Risk ofObesity in Offspring in Childhood, Adolescence, and EarlyAdulthood. JAMA pediatrics. 2016;170(11):e162385.

  35. Pluymen LP, Smit HA, Wijga AH, Gehring U, De Jongste JC,Van Rossem L. Cesarean Delivery, Overweight throughoutChildhood, and Blood Pressure in Adolescence. The Journalof pediatrics. 2016;179:111-7.e3.




2020     |     www.medigraphic.com